Tandem Diabetes Care (NASDAQ:TNDM) Advances 4.7% This Week, Taking One-year Gains to 115%

Simply Wall StSep 26 18:45

Morgan Stanley Maintains Equal-Weight on Tandem Diabetes Care, Maintains $45 Price Target

BenzingaSep 24 01:12 · Ratings

Tandem Diabetes Care Analyst Ratings

BenzingaSep 24 01:11 · Ratings

TNDM Stock Likely to Gain From Innovation Amid Competition

Zacks Sep 23 20:35

Stifel Nicolaus Sticks to Their Buy Rating for Tandem Diabetes Care (TNDM)

TipRanksSep 23 19:56 · Ratings

Why Tandem Diabetes Care Stock Thrashed the Market Today

Yahoo FinanceSep 20 06:49